Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia
Results
Phase 3
This trial was to see if longer but less intensive chemotherapy worked as well as chemotherapy for acute promyelocytic leukaemia (APML). And to see if adding a drug called gemtuzumab ozogamicin (also known as Mylotarg) improved either treatment plan.
Recruitment start: 1 May 2002
Recruitment end: 30 June 2007
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor A K Burnett
Experimental Cancer Medicine Centre (ECMC)
Medical Research Council (MRC)
NIHR Clinical Research Network: Cancer
Last reviewed: 22 Aug 2013
CRUK internal database number: 7114
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
